The DOI matches its Crossref record, with a small difference in title or year; 65 of the 70 references it cites were found in a registry or an index.
Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer
Open accessAbstract
Prostate tumor growth initially depends on androgens, which act via the androgen receptor (AR). Despite androgen ablation therapy, tumors eventually progress to a castrate-resistant stage in which the AR remains active. The mechanisms are poorly understood but it may be that changes in levels or activity of AR coregulators affect trafficking and activation of the receptor. A key stage in AR signaling occurs in the cytoplasm, where unliganded receptor is associated with the heat shock protein (HSP)90 foldosome complex. p23, a key component of this complex, is best characterized as a cochaperone for HSP90 but also has HSP90-independent activity and has been reported as having differential effects on the activity of different steroid receptors. Here we report that p23 increases activity of the AR, and this appears to involve steps both in the cytoplasm (increasing ligand-binding capacity, possibly via direct interaction with AR) and the nucleus (enhancing AR occupancy at target promoters). We show, for the first time, that AR and p23 can interact, perhaps directly, when HSP90 is not present in the same complex. The effects of p23 on AR activity are at least partly HSP90 independent because a mutant form of p23, unable to bind HSP90, nevertheless increases AR activity. In human prostate tumors, nuclear p23 was higher in malignant prostate cells compared with benign/normal cells, supporting the utility of p23 as a therapeutic target in prostate cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PTGES3 is reported to have a cytosolic HSP90-dependent protein chaperone function for steroid nuclear receptors”
From Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer (2025) · cites this paper as [41]
In the citing paper
“The proposed PGE2 enzymatic site is at the N terminus of the protein whereas the proposed HSP90 interaction motif is at the C terminus of the protein41,47.”
From Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer (2025) · cites this paper as [41]
In the citing paper
“PTGES3 protein is reported to have several protein functions and to be localized to both the cytosol and nucleus41–49 (Fig. 3f).”
From Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer (2025) · cites this paper as [41]
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
MOLECULAR CHAPERONE FUNCTIONS OF HEAT-SHOCK PROTEINS
Hendrick, J. P., & Hartl, F.-U. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002025 · Cited by 1,638
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
The glucocorticoid receptor: rapid exchange with regulatory sites in living cells
McNally, J. G., Müller, W. G., Walker, D., Wolford, R., & Hager, G. L. (2000) · Science · doi:10.1126/science.287.5456.1262 · Cited by 802
Nuclear Receptor Coregulators: Cellular and Molecular Biology
McKenna, N. J. (1999) · Endocrine Reviews · doi:10.1210/er.20.3.321 · Cited by 782
Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003504200 · Cited by 708 · cited 2×
“prostaglandin synthase activity (22) as well as a role in reg-”
BackgroundPratt, W. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80556-0 · Cited by 653
Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., & Brinkmann, A. O. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1396 · Cited by 523 · cited 1×
“The following plasmids have been described previously: pSG5-SRC-1e (36), pSVAR LBD (amino acids 1–653) (37), pGAD424-ARNTD, and pGAD424-ARLBD (38).”
The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1
Bevan, C. L., Hoare, S., Claessens, F., Heery, D. M., & Parker, M. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8383 · Cited by 425
Self-citationZhou, Z. X. (1995) · Molecular Endocrinology · doi:10.1210/me.9.2.208 · Cited by 411
Novobiocin and Related Coumarins and Depletion of Heat Shock Protein 90-Dependent Signaling Proteins
Marcu, M. G., Schulte, T. W., & Neckers, L. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.242 · Cited by 405
Disassembly of Transcriptional Regulatory Complexes by Molecular Chaperones
Freeman, B. C., & Yamamoto, K. R. (2002) · Science · doi:10.1126/science.1073051 · Cited by 400 · cited 9×
“In an important subsequent study they demonstrated a nuclear role of p23, whereby p23 overexpression promotes disassembly of the transcriptional machinery at hormone response elements, resulting, in this case, in a reduction in GR activity (12).”
BackgroundInfluentialChaperone Function of Hsp90-Associated Proteins
Bose, S., Weikl, T., Bügl, H., & Buchner, J. (1996) · Science · doi:10.1126/science.274.5293.1715 · Cited by 371
Freeman, B. C., Toft, D. O., & Morimoto, R. I. (1996) · Science · doi:10.1126/science.274.5293.1718 · Cited by 370
Kalkhoven, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.232 · Cited by 314
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors
Powers, M. V., & Workman, P. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01324 · Cited by 285
Rapid signalling by androgen receptor in prostate cancer cells
Peterziel, H., Mink, S., Schonert, A., Becker, M., Klocker, H., & Cato, A. C. (1999) · Oncogene · doi:10.1038/sj.onc.1203032 · Cited by 271
Folding of the Glucocorticoid Receptor by the Heat Shock Protein (hsp) 90-based Chaperone Machinery
Dittmar, K. D., Demady, D. R., Stancato, L. F., Krishna, P., & Pratt, W. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21213 · Cited by 268
The role of the androgen receptor in the development and progression of prostate cancer.
Jenster, G. W. (1999) · PubMed · Cited by 239
Nucleotides and Two Functional States of hsp90
Sullivan, W., Stensgard, B., Caucutt, G., Bartha, B., McMahon, N., Alnemri, E. S., Litwack, G., & Toft, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8007 · Cited by 238
Binding of p23 and hsp90 during assembly with the progesterone receptor.
Johnson, J. L., & Toft, D. O. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.6.8592513 · Cited by 233
Johnson, J. L., & Toft, D. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31487-4 · Cited by 229
Smith, D. F., Faber, L. E., & Toft, D. O. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39693-0 · Cited by 221
The Co-chaperone p23 Arrests the Hsp90 ATPase Cycle to Trap Client Proteins
McLaughlin, S. H., Sobott, F., Yao, Z.-P., Zhang, W., Nielsen, P. R., Grossmann, J. G., Laue, E. D., Robinson, C. V., & Jackson, S. E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.085 · Cited by 196 · cited 1×
“(30), it could also be a target to reduce HSP90 activity within”
BackgroundDodou, E., & Treisman, R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1848 · Cited by 194
BAG-1L Protein Enhances Androgen Receptor Function
Froesch, B. A., Takayama, S., & Reed, J. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11660 · Cited by 193
SBA1 Encodes a Yeast Hsp90 Cochaperone That Is Homologous to Vertebrate p23 Proteins
Fang, Y., Fliss, A., Rao, J., & Caplan, A. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3727 · Cited by 174
Smith, D. F., & Toft, D. O. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0089 · Cited by 173
Molecular chaperones function as steroid receptor nuclear mobility factors
Elbi, C., Walker, D. A., Romero, G. G., Sullivan, W. P., Toft, D. O., Hager, G. L., & DeFranco, D. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400116101 · Cited by 170
Freeman, B. C., Felts, S. J., Toft, D. O., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.14.4.422 · Cited by 168 · cited 4×
“(15) reported it as inhibiting AR activity, whereas Fang et al.”
BackgroundInfluentialHutchison, K. A., Dittmar, K. D., Czar, M. J., & Pratt, W. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37651-2 · Cited by 165
The Hsp90 complex—a super-chaperone machine as a novel drug target
Scheibel, T., & Buchner, J. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00120-8 · Cited by 164
Dittmar, K. D., Banach, M., Galigniana, M. D., & Pratt, W. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7358 · Cited by 163
The Function of Steroid Hormone Receptors Is Inhibited by the hsp90-specific Compound Geldanamycin
Segnitz, B., & Gehring, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18694 · Cited by 161
Ranea, J. A. G., Mirey, G., Camonis, J., & Valencia, A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03321-5 · Cited by 160
Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor
Belandia, B., Powell, S. M., Garcia-Pedrero, J. M., Walker, M. M., Bevan, C. L., & Parker, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1425-1436.2005 · Cited by 153
Self-citationCrystal Structure and Activity of Human p23, a Heat Shock Protein 90 Co-chaperone
Weaver, A. J., Sullivan, W. P., Felts, S. J., Owen, B. A. L., & Toft, D. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003410200 · Cited by 136
Role for Hsp90-Associated Cochaperone p23 in Estrogen Receptor Signal Transduction
Knoblauch, R., & Garabedian, M. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3748 · Cited by 126
Hutchison, K. A., Stancato, L. F., Owens-Grillo, J. K., Johnson, J. L., Krishna, P., Toft, D. O., & Pratt, W. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18841 · Cited by 121
Bagatell, R., Khan, O., Paine-Murrieta, G. D., Taylor, C. W., Akinaga, S., & Whitesell, L. J. (2001) · PubMed · Cited by 118
Change of Specificity Mutations in Androgen-selective Enhancers
Verrijdt, G., Schoenmakers, E., Haelens, A., Peeters, B., Verhoeven, G., Rombauts, W., & Claessens, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12298 · Cited by 107
Weikl, T., Abelmann, K., & Buchner, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3172 · Cited by 97 · cited 2×
“Several of these activities may be partly or wholly independent of HSP90, including chaperone function: the C-terminal tail of p23 has intrinsic chaperone activity and even p23 variants lacking the HSP90-interacting domain retain chaperone function (20, 31).”
BackgroundChristiaens, V., Bevan, C. L., Callewaert, L., Haelens, A., Verrijdt, G., Rombauts, W., & Claessens, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209322200 · Cited by 90
Self-citationA novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
Akalin, A., Elmore, L. W., Forsythe, H. L., Amaker, B. A., McCollum, E. D., Nelson, P. S., Ware, J. L., & Holt, S. E. (2001) · PubMed · Cited by 90
p23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity
Forafonov, F., Toogun, O. A., Grad, I., Suslova, E., Freeman, B. C., & Picard, D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02246-07 · Cited by 84
Hsp90 as an anti-cancer target
Neckers, L., Mimnaugh, E. G., & Schulte, T. W. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0082 · Cited by 83
Continuous recycling: a mechanism for modulatory signal transduction.
Freeman, B. C., & Yamamoto, K. R. (2001) · TIBS -Trends in Biochemical Sciences. Regular ed · doi:10.1016/s0968-0004(01)01834-5 · Cited by 81
Rao, R. V., Niazi, K. R., Mollahan, P., Mao, X. O., Crippen, D., Poksay, K. S., Chen, S., & Bredesen, D. E. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401761 · Cited by 81
Brooke, G. N., Parker, M. G., & Bevan, C. L. (2008) · Oncogene · doi:10.1038/sj.onc.1210955 · Cited by 79 · cited 1×
“Luciferase data were normalized to -galactosidase activity, as previously described (42).”
MethodSelf-citationLocalization of Sites of Interaction between p23 and Hsp90 in Solution
Martinez‐Yamout, M. A., Venkitakrishnan, R. P., Preece, N. E., Kroon, G. J. A., Wright, P. E., & Dyson, H. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601759200 · Cited by 75
Simpson, N. E., Lambert, W. M., Watkins, R. A., Giashuddin, S. M., Huang, S.-T. J., Oxelmark, E., Arju, R., Hochman, T., Goldberg, J. D., Schneider, R. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1590 · Cited by 67
ALG-2: a Ca2+-binding modulator protein involved in cell proliferation and in cell death
Krebs, J. J. R., Saremaslani, P., & Caduff, R. F. (2002) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(02)00446-6 · Cited by 58
The p23 molecular chaperone promotes functional telomerase complexes through DNA dissociation
Toogun, O. A., Zeiger, W., & Freeman, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701442104 · Cited by 55
Oxelmark, E., Roth, J., Brooks, P., Braunstein, S., Schneider, R., & Garabedian, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00009-06 · Cited by 53
Dart, D. A., Spencer‐Dene, B., Gamble, S. C., Waxman, J., & Bevan, C. L. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0028 · Cited by 53
Self-citationInhibition of GR‐mediated transcription by p23 requires interaction with Hsp90
Wochnik, G. M., Young, J. C., Schmidt, U., Holsboer, F., Hartl, F. U., & Rein, T. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00066-3 · Cited by 44
Molt cycle–dependent molecular chaperone and polyubiquitin gene expression in lobster
Spees, J. L., Chang, S. A., Mykles, D. L., Snyder, M. J., & Chang, E. S. (2003) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2003)008<0258:mcmcap>2.0.co;2 · Cited by 43
McKenna, N. J., & O’Malley, B. W. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111665 · Cited by 39
Oxelmark, E., Knoblauch, R. E., Arnal, S. M., Su, L. F., Schapira, M., & Garabedian, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305960200 · Cited by 38
Whitaker, H. C., Hanrahan, S. J., Totty, N., Gamble, S. C., Waxman, J., Cato, A. C. B., Hurst, H. C., & Bevan, C. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0388 · Cited by 38
Self-citationProperties of the co‐chaperone protein p23 erroneously attributed to ALG‐2 (apoptosis‐linked gene 2)
Mollerup, J., Krogh, T. N., Nielsen, P. F., & Berchtold, M. W. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01310-3 · Cited by 32
Composition, assembly and activation of the avian progesterone receptor
Smith, D. F., & Toft, D. O. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90345-j · Cited by 19
Elmore (1994) · Oncology Reports · doi:10.3892/or_00000049 · Cited by 18
Cited by
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
He, Y., Peng, S., Wang, J., Chen, H., Cong, X., Chen, A., Hu, M., Qin, M., Wu, H., Gao, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13122 · Cited by 108
The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer
Sprenger, C. C. T., & Plymate, S. R. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0177-y · Cited by 93
“Because the Hsp90 binding site is located in exon 7, the AR-Vs are not tethered by this Hsp in the cytoplasm and may be transported directly to the nucleus where they are constitutively active [53].”
Campanella, C., D’Anneo, A., Marino, A., Bavisotto, C. C., Barone, R., Emanuele, S., Cascio, F. L., Mocciaro, E., Fais, S., de Macario, E. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6680 · Cited by 74
Mini-review: Foldosome regulation of androgen receptor action in prostate cancer
Cano, L. Q., Lavery, D. N., & Bevan, C. L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.023 · Cited by 81
Self-citation17β-Estradiol and testosterone in sarcopenia: Role of satellite cells
la Colla, A. B., Pronsato, L., Milanesi, L. M., & Vasconsuelo, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.011 · Cited by 84
“In view of that, these HSPs are able to interact with ERs or AR stabilizating them (Reebye et al., 2012; Zoubeidi et al., 2007).”
Metadata
- Authors
- Reebye, V., Querol Cano, L., Lavery, D. N., Brooke, G. N., Powell, S. M., Chotai, D., Walker, M. M., Whitaker, H. C., Wait, R., Hurst, H. C., & Bevan, C. L.
- Affiliations
- Queen Mary University of London (GB)
- Androgen Signalling Laboratory (V.R., L.Q.C., G.N.B., S.M.P., D.N.L., D.C., C.L.B.), Department of Surgery & Cancer, Imperial College London, London W12 0NN, United Kingdom;
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2012-10-01
- Volume
- 26
- Issue
- 10
- Pages
- 1694-1706
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC5416955
- OpenAlex
- W2154329747
- Semantic Scholar
- e7e99834a7409b925b516324eecbbe4862df9d5d
- Cited by
- 47
- References
- 70
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 7
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Open Access at Essex (University of Essex) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Cancer Research UK
- Imperial College London
- Université de Genève
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- p23, androgen receptor, HSP90, co-chaperones, prostate cancer, castration-resistant prostate cancer, therapeutic target
- MeSH terms
- Prostaglandin-E Synthases, Animals, Cell Line, Cell Nucleus, Chlorocebus aethiops, Enhancer Elements, Genetic, Humans, Male, Prostatic Neoplasms, Protein Binding, Receptors, Androgen, Receptors, Glucocorticoid, Transcriptional Activation, Gene Expression, Prostate-Specific Antigen, HSP90 Heat-Shock Proteins, Intramolecular Oxidoreductases, Two-Hybrid System Techniques, Tissue Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.